Page last updated: 2024-11-02

pentobarbital and Osteoarthritis

pentobarbital has been researched along with Osteoarthritis in 1 studies

Pentobarbital: A short-acting barbiturate that is effective as a sedative and hypnotic (but not as an anti-anxiety) agent and is usually given orally. It is prescribed more frequently for sleep induction than for sedation but, like similar agents, may lose its effectiveness by the second week of continued administration. (From AMA Drug Evaluations Annual, 1994, p236)
pentobarbital : A member of the class of barbiturates, the structure of which is that of barbituric acid substituted at C-5 by ethyl and sec-pentyl groups.

Osteoarthritis: A progressive, degenerative joint disease, the most common form of arthritis, especially in older persons. The disease is thought to result not from the aging process but from biochemical changes and biomechanical stresses affecting articular cartilage. In the foreign literature it is often called osteoarthrosis deformans.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Zou, Y1
Liu, Q1
Guo, P1
Huang, Y1
Ye, Z1
Hu, J1

Other Studies

1 other study available for pentobarbital and Osteoarthritis

ArticleYear
Anti‑chondrocyte apoptosis effect of genistein in treating inflammation‑induced osteoarthritis.
    Molecular medicine reports, 2020, Volume: 22, Issue:3

    Topics: Aggrecans; Animals; Anti-Inflammatory Agents, Non-Steroidal; Caspase 3; Cell Survival; Cells, Cultur

2020